JKJohn R. W. Kestle

John R. W. Kestle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John R. W. Kestle has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Advantages of the double-incision approach in endoscopic management of unicoronal synostosis

    by Joy Ha, Tae Hwan Park, Barbu Gociman, John R. W. Kestle

    Endoscopic strip craniectomy followed by postoperative helmet therapy has become a well-established treatment for single-suture craniosynostosis. Several incision patterns have been described in the medical literature. In this study, we describe a double-incision endoscopic strip craniectomy technique for unicoronal synostosis and discuss its technical pearls and potential advantages. Our endoscopic strip craniectomy technique for unicoronal synostosis uses two incisions. Patients typically present ipsilateral forehead flattening, contralateral frontal bossing, and harlequin eye deformity, with CT imaging confirming isolated premature fusion of one coronal suture. Endoscopic strip craniectomy is performed using two incisions (approximately 2 to 3 cm each) near the anterior fontanelle and the squamosal suture. A 1-cm-wide strip craniectomy is performed under endoscopic visualization, with additional barrel stave osteotomies performed under direct visualization. The temporalis muscle is elevated and resuspended using drill holes at the craniotomy edge. Patients are typically discharged on postoperative day 1. Helmet therapy is initiated 2 weeks postoperatively and continues for 9-12 months. Early follow-up demonstrates significant improvement in forehead and orbital symmetry, with well-healed incisions. Follow-up through 5 years of age demonstrates favorable cranial and facial contour with no significant residual deformity. Developmental and ophthalmologic evaluations remain within normal limits, and additional surgical intervention for craniosynostosis is not typically required. A double-incision endoscopic strip craniectomy technique optimizes surgical exposure while minimizing scar-related morbidity. This approach ensures extension of the craniectomy to the anterior fontanelle and the squamosal suture and facilitates barrel stave osteotomies and temporalis muscle resuspension.

  • Editorial. Spinning all around

    by John R. W. Kestle

    "Editorial. Spinning all around" published on 10 May 2024 by American Association of Neurological Surgeons.

  • Randomized Clinical Trials in Pediatric Hydrocephalus

    by Evan J. Joyce, Jay Riva-Cambrin, John R. W. Kestle


  • A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection

    by John R. W. Kestle, Richard Holubkov, D. Douglas Cochrane, Abhaya V. Kulkarni, David D. Limbrick Jr., Thomas G. Luerssen, W. Jerry Oakes, Jay Riva-Cambrin, Curtis Rozzelle, Tamara D. Simon, et al.

    OBJECT: In a previous report by the same research group (Kestle et al., 2011), compliance with an 11-step protocol was shown to reduce CSF shunt infection at Hydrocephalus Clinical Research Network (HCRN) centers (from 8.7% to 5.7%). Antibiotic-impregnated catheters (AICs) were not part of the protocol but were used off protocol by some surgeons. The authors therefore began using a new protocol that included AICs in an effort to reduce the infection rate further. METHODS: The new protocol was implemented at HCRN centers on January 1, 2012, for all shunt procedures (excluding external ventricular drains [EVDs], ventricular reservoirs, and subgaleal shunts). Procedures performed up to September 30, 2013, were included (21 months). Compliance with the protocol and outcome events up to March 30, 2014, were recorded. The definition of infection was unchanged from the authors' previous report. RESULTS: A total of 1935 procedures were performed on 1670 patients at 8 HCRN centers. The overall infection rate was 6.0% (95% CI 5.1%–7.2%). Procedure-specific infection rates varied (insertion 5.0%, revision 5.4%, insertion after EVD 8.3%, and insertion after treatment of infection 12.6%). Full compliance with the protocol occurred in 77% of procedures. The infection rate was 5.0% after compliant procedures and 8.7% after noncompliant procedures (p = 0.005). The infection rate when using this new protocol (6.0%, 95% CI 5.1%–7.2%) was similar to the infection rate observed using the authors' old protocol (5.7%, 95% CI 4.6%–7.0%). CONCLUSIONS: CSF shunt procedures performed in compliance with a new infection prevention protocol at HCRN centers had a lower infection rate than noncompliant procedures. Implementation of the new protocol (including AICs) was associated with a 6.0% infection rate, similar to the infection rate of 5.7% from the authors' previously reported protocol. Based on the current data, the role of AICs compared with other infection prevention measures is unclear.


  • Top Cited Papers

    A standardized protocol to reduce cerebrospinal fluid shunt infection: The Hydrocephalus Clinical Research Network Quality Improvement Initiative

    by John R. W. Kestle, Jay Riva-Cambrin, John C. Wellons, Abhaya V. Kulkarni, William E. Whitehead, Marion L. Walker, W. Jerry Oakes, James M. Drake, Thomas G. Luerssen, Tamara D. Simon, et al.

    Object: Quality improvement techniques are being implemented in many areas of medicine. In an effort to reduce the ventriculoperitoneal shunt infection rate, a standardized protocol was developed and implemented at 4 centers of the Hydrocephalus Clinical Research Network (HCRN). Methods: The protocol was developed sequentially by HCRN members using the current literature and prior institutional experience until consensus was obtained. The protocol was prospectively applied at each HCRN center to all children undergoing a shunt insertion or revision procedure. Infections were defined on the basis of CSF, wound, or pseudocyst cultures; wound breakdown; abdominal pseudocyst; or positive blood cultures in the presence of a ventriculoatrial shunt. Procedures and infections were measured before and after protocol implementation. Results: Twenty-one surgeons at 4 centers performed 1571 procedures between June 1, 2007, and February 28, 2009. The minimum follow-up was 6 months. The Network infection rate decreased from 8.8% prior to the protocol to 5.7% while using the protocol (p = 0.0028, absolute risk reduction 3.15%, relative risk reduction 36%). Three of 4 centers lowered their infection rate. Shunt surgery after external ventricular drainage (with or without prior infection) had the highest infection rate. Overall protocol compliance was 74.5% and improved over the course of the observation period. Based on logistic regression analysis, the use of BioGlide catheters (odds ratio [OR] 1.91, 95% CI 1.19–3.05; p = 0.007) and the use of antiseptic cream by any members of the surgical team (instead of a formal surgical scrub by all members of the surgical team; OR 4.53, 95% CI 1.43–14.41; p = 0.01) were associated with an increased risk of infection. Conclusions: The standardized protocol for shunt surgery significantly reduced shunt infection across the HCRN. Overall protocol compliance was good. The protocol has established a common baseline within the Network, which will facilitate assessment of new treatments. Identification of factors associated with infection will allow further protocol refinement in the future.


  • Outcomes after surgery for focal epilepsy in children

    by Peter Kan, Colin Van Orman, John R. W. Kestle

    Surgery is an effective treatment for selected patients with intractable epilepsy. The authors report the outcomes of focal resection in a series of children suffering from intractable focal epilepsy treated at a single institution. The authors retrospectively analyzed a series of 58 consecutive children who underwent surgery between 1998 and 2006 for intractable localized epilepsy at Primary Children’s Medical Center. Evaluation for surgery and follow-up was performed by the authors in the combined Pediatric Epilepsy Surgery Clinic. Preoperative seizure duration ranged from 6 months to 15 years. The cause of epilepsy was mesial temporal sclerosis (MTS) in 16 patients, dual pathology (MTS plus another lesion) in 3 patients, low-grade tumors in 16 patients, cortical dysplasia (CD) in 13 patients, cavernous malformation (CM) in 5 patients, and other conditions in 5 patients. In 33 cases, the lesions were in the temporal lobe, and in 25 cases, the lesions were extratemporal. At last follow-up, 74% (43/58) of all patients were seizure-free; seizure-free rates for specific conditions were 88% (14/16) for MTS, 33% (1/3) for dual pathology, 81% (13/16) for tumor, 62% (8/13) for CD, and 80% (4/5) for CM. Seizure-free rates were 85% (28/33) for temporal locations and 60% (15/25) for extratemporal locations. There were no permanent neurological complications or deaths. Surgery for localized epilepsy in carefully selected children has good seizure control rates with minimal complications. Outcomes for patients with resections in temporal locations were better than those for patients with extratemporal resections.


  • Surgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantation

    by Peter Kan, Judith Gooch, Aminullah Amini, Diana Ploeger, Barbara Grams, Wende Oberg, Sara Simonsen, Marion Walker, John Kestle

    Neurosurgical treatments for spasticity in children include the traditional selective dorsal rhizotomy (SDR) and intrathecal baclofen pumps (ITBPs), which have been widely used in the past decade as an attractive alternative. The purpose of the study was to examine and compare the outcomes of these two procedures in the treatment of children with severe spasticity. A consecutive series of 71 children who underwent SDR for treatment of spasticity was compared with a group of 71 children matched by age and preoperative score on the Gross Motor Function Classification System (GMFCS) who underwent ITBP placement. Change in GMFCS score, lower-extremity tone (based on the Modified Ashworth–Bohannon Scale), and lower-extremity passive range of movement (PROM) at 1 year as well as the need for subsequent orthopedic procedures and parents’ satisfaction were selected as outcome measures. At 1 year, both SDR and ITBP decreased tone, increased PROM, and improved function. Both procedures resulted in a high degree of patient satisfaction. Compared with ITBP, SDR provided a larger magnitude of improvement in tone (−2.52 vs −1.23, p < 0.0001), PROM (−0.77 vs −0.39, p = 0.0138), and gross motor function (−0.66 vs −0.08, p < 0.0001). In addition, fewer patients in the SDR group required subsequent orthopedic procedures (19.1 vs 40.8%, p = 0.0106). For children with moderate to severe spasticity, SDR and ITBP are both effective surgical treatments. Our results indicate SDR is more effective in reducing the degree of spasticity and improving function than ITBP is in this group of patients.


  • Cellular phone use and brain tumor: a meta-analysis

    by Peter Kan, Sara E. Simonsen, Joseph L. Lyon, John R. W. Kestle

    The dramatic increase in the use of cellular phones has generated concerns about potential adverse effects, especially the development of brain tumors. We conducted a meta-analysis to examine the effect of cellular phone use on the risk of brain tumor development. We searched the literature using MEDLINE to locate case-control studies on cellular phone use and brain tumors. Odds ratios (ORs) for overall effect and stratified ORs associated with specific brain tumors, long-term use, and analog/digital phones were calculated for each study using its original data. A pooled estimator of each OR was then calculated using a random-effects model. Nine case-control studies containing 5,259 cases of primary brain tumors and 12,074 controls were included. All studies reported ORs according to brain tumor subtypes, and five provided ORs on patients with ≥10 years of follow up. Pooled analysis showed an overall OR of 0.90 (95% confidence interval [CI] 0.81–0.99) for cellular phone use and brain tumor development. The pooled OR for long-term users of ≥10 years (5 studies) was 1.25 (95% CI 1.01–1.54). No increased risk was observed in analog or digital cellular phone users. We found no overall increased risk of brain tumors among cellular phone users. The potential elevated risk of brain tumors after long-term cellular phone use awaits confirmation by future studies.